| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.373 | 2.892 | 1.877 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 11.407 | 54.781 | 2.485 | 416 | 22.066 | 0 | 41.856 | 0 | 0 | 19.117 |
| Total Expenses - EUR | 6.193 | 4.566 | 4.849 | 3.812 | 3.257 | 31.693 | 2.067 | 1.485 | 61 | 636 |
| Gross Profit/Loss - EUR | 5.214 | 50.215 | -2.364 | -3.397 | 18.809 | -31.693 | 39.790 | -1.485 | -61 | 18.481 |
| Net Profit/Loss - EUR | 5.137 | 50.128 | -2.438 | -3.397 | 18.809 | -31.693 | 39.776 | -1.485 | -61 | 15.790 |
| Employees | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Z Group Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 428.104 | 478.696 | 473.375 | 438.774 | 459.298 | 421.943 | 454.431 | 455.841 | 454.398 | 513.217 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.800 | 3.479 | 3.764 | 727 | 891 | 892 | 1.014 | 1.017 | 1.025 | 1.092 |
| Cash | 426.304 | 475.217 | 469.611 | 438.047 | 458.407 | 421.050 | 453.418 | 454.824 | 453.373 | 512.125 |
| Shareholders Funds | 351.648 | 398.189 | 389.013 | 353.101 | 371.939 | 334.682 | 367.036 | 366.690 | 365.517 | 420.870 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 76.456 | 80.507 | 84.362 | 85.674 | 87.358 | 87.261 | 87.395 | 89.151 | 88.881 | 92.347 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Z Group Pharma Srl